Extended Anti-CD20 Dosing Shows Promise for Multiple Sclerosis Safety
A collaborative expert review highlights that extending anti-CD20 infusion intervals in stable multiple sclerosis patients may preserve neuroinflammatory disease control ...
A collaborative expert review highlights that extending anti-CD20 infusion intervals in stable multiple sclerosis patients may preserve neuroinflammatory disease control ...
A Danish nationwide registry study found lower short-term relapse rates and few confirmed disability-worsening events among people with relapsing–remitting multiple ...
A two-year real-world study found that ofatumumab sustained B-cell depletion in multiple sclerosis patients while producing significant increases in broad ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.